When did CO-DIAGNOSTICS INC (CODX) report earnings last quarter?
CO-DIAGNOSTICS INC (CODX) last reported earnings on 3/19/2026.
NASDAQ:CODX • US1897632048
Past quarterly earnings results for CO-DIAGNOSTICS INC (CODX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -4.80 | -4.90 | 1.96% | 50.00% | 145K | 153K | -5.23% | -77.38% |
| Q2 2025 | -6.90 | -18.97 | 63.63% | -64.29% | 163K | 153K | 6.54% | -93.87% |
| Q1 2025 | -7.20 | -10.10 | 28.70% | 22.58% | 50.28K | 382.5K | -86.85% | -89.25% |
| Q4 2024 | -10.80 | -10.40 | -3.81% | 28.00% | 149K | 382.5K | -61.05% | -95.81% |
| Q3 2024 | -9.60 | -10.10 | 4.93% | -60.00% | 641.14K | 382.5K | 67.62% | -73.91% |
| Q2 2024 | -4.20 | -10.40 | 59.63% | 54.84% | 2.657M | 382.5K | 594.64% | 1,241.92% |
| Q1 2024 | -9.30 | -6.43 | -44.72% | -55.00% | 467.85K | 3.111M | -84.96% | -22.15% |
| Q4 2023 | -15.00 | -6.12 | -145.10% | 26.47% | 3.555M | 3.698M | -3.86% | 153.94% |
| Q3 2023 | -6.00 | -8.87 | 32.39% | -400.00% | 2.457M | 204K | 1,104.41% | -51.73% |
| Q2 2023 | -9.30 | -7.34 | -26.63% | -287.50% | 198K | 510K | -61.18% | -96.06% |
| Q1 2023 | -6.00 | -6.89 | 12.85% | -158.82% | 601K | 1.122M | -46.43% | -97.35% |
| Q4 2022 | -20.40 | -4.59 | -344.44% | -372.00% | 1.4M | 5.61M | -75.04% | -93.14% |
| Q3 2022 | -1.20 | -1.30 | 7.73% | -110.53% | 5.09M | 8.137M | -37.45% | -83.09% |
| Q2 2022 | -2.40 | 2.96 | -181.13% | -124.24% | 5.02M | 20.91M | -75.99% | -81.65% |
| Q1 2022 | 10.20 | 5.30 | 92.31% | 30.77% | 22.7M | 21.59M | 5.14% | 13.39% |
| Q4 2021 | 7.50 | 3.67 | 104.25% | -44.44% | 20.4M | 21.351M | -4.45% | -24.86% |
| Q3 2021 | 11.40 | 6.32 | 80.26% | -28.30% | 30.1M | 24.803M | 21.36% | 37.95% |
| Q2 2021 | 9.90 | 6.73 | 47.06% | -23.26% | 27.36M | 21.181M | 29.17% | 13.81% |
| Q1 2021 | 7.80 | 6.73 | 15.86% | 620.00% | 20.02M | 20.29M | -1.33% | 1,191.61% |
| Q4 2020 | 13.50 | 14.59 | -7.45% | - | 27.15M | 25.492M | 6.50% | - |
| Q3 2020 | 15.90 | 19.38 | -17.96% | - | 21.82M | 33.451M | -34.77% | - |
| Q2 2020 | 12.90 | 17.95 | -28.14% | - | 24.04M | 26.978M | -10.89% | - |
| Q1 2020 | -1.50 | -1.63 | 8.08% | - | 1.55M | 628.657K | 146.56% | - |
Notes
CO-DIAGNOSTICS INC (CODX) last reported earnings on 3/19/2026.
CO-DIAGNOSTICS INC (CODX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, CO-DIAGNOSTICS INC (CODX) has beaten EPS estimates in 3 out of 4 releases.